Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60008 |
BCL6-IN-6
|
BCL | Apoptosis |
BCL6-IN-6 是 Bcl-6 的抑制剂,可用于关于弥漫性大 B 细胞淋巴瘤的研究。 BCL6-IN-6 阻断 Bcl-6 与其辅阻遏物的相互作用,并以剂量依赖性方式重新激活 Bcl-6 靶基因。 | |||
T10487 |
BCL6-IN-3
|
BCL; Others; DNA | Apoptosis; DNA Damage/DNA Repair; Others |
BCL6-IN-3是一种有效的BCL6抑制剂,对SU-DHL4细胞中的GI50为70 nM。BCL6- in -3调控细胞活化、分化、DNA 损伤和凋亡过程,具有抗肿瘤活性。 | |||
T39788 |
BCL6-IN-5
BCL6-IN-5 |
||
BCL6-IN-5 is a highly effective inhibitor of BCL6. It exhibits a pIC50 value of 5.82. | |||
T14515 | BCL6-IN-8c | Others | Others |
BCL6-IN-8c is an orally active and potent inhibitor of B-cell lymphoma 6 (BCL6)-corepressor interaction(IC50 of 0.10 μM in cell-free enzyme-linked immunosorbent assay). | |||
T36484 |
BCL6-IN-4
BCL6-IN-4 |
||
BCL6-IN-4, a potent inhibitor of B-cell lymphoma 6 (BCL6), exhibits anti-tumor activities with an inhibitory concentration 50 (IC50) value of 97 nM[1]. | |||
T73869 | BCL6 PROTAC 1 | ||
BCL6PROTAC1 是一种选择性的 B 细胞淋巴瘤 6 (BCL6)PROTAC。BCL6PROTAC1 抑制 BCL6 细胞报告,IC50值为 8.8 µM。BCL6PROTAC1 在弥漫性大 B 细胞淋巴瘤 (DLBCL) 细胞系中显著降解 BCL6。BCL6PROTAC1 可用于肿瘤相关研究。 | |||
T3940 |
CID5721353
BCL6 inhibitor |
Apoptosis; BCL | Apoptosis |
CID5721353 (BCL6 inhibitor) 是一种 B 细胞淋巴瘤 6 抑制剂,IC50为 212 μM,Ki 值为 147 μM。它可在体内外破坏 BCL6/辅助阻遏物复合物,并显示与 BTB 沟内的关键位点结合。 | |||
T62854 |
BCL6-IN-9
|
||
BCL6-IN-9 (compound 1) 是一种 B 细胞淋巴瘤 6 蛋白 (BCL6) 的有效抑制剂 (IC50: 3.9 nM),能够用于研究癌。 | |||
T75105 | OICR12694 TFA | ||
OICR12694 (JNJ-65234637) TFA 是一种口服有效的 B 细胞淋巴瘤 6 (BCL6) 抑制剂。 |